Consequences of peripheral vasculopathy, like Raynaud’s phenomenon, had been noticed in postmarketing studies and on the therapeutic dosages of CNS stimulants in all age teams all over the course of cure. Signals and symptoms typically enhanced after dosage reduction or discontinuation of the CNS stimulant.Sudden Dying continues to be documented